SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about annual report

26 Aug 2022 Evaluate
Bal Pharma has informed that the 35th Annual General Meeting of the Company is scheduled to be held on 19th September 2022 at 11.30 AM through audio visual means. Notice along with the details of the business to be transacted at the meeting and audited financial statements of the Company for the FY ended 30.03.2022 together with the reports of Directors and auditors there on is being dispatched to shareholders through electronic form. A copy of the unabridged annual report of the Company for the financial year ended 31.03.2022 is enclosed for submission to the exchanges. Annual report for FY2021-22 is also available on its website i.e., www.balpharma.com

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

77.01 -1.46 (-1.86%)
21-Apr-2026 10:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.10
Dr. Reddys Lab 1223.40
Cipla 1232.65
Zydus Lifesciences 932.25
Lupin 2327.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×